relaxations of both the MA and RA (n=13 and n=8, respectively; Figure 1B and 1C). As it has previously been shown that BK Ca channels have a role in this process, 18 we inhibited this channel with 1 μmol/L paxilline, which produced an impairment of the EPAC-dependent relaxation in both MA and RA (n=5) but not complete blockade. To investigate the role of Kv7 channels, we used the pan-Kv7 channel blocker linopirdine, which inhibited 8-pCPT-2Me-cAMP-AM-mediated relaxations in MA at both 1 and 10 μmol/L (n=6). In combination, paxilline and linopirdine produced an additive inhibition of EPAC relaxation in the MA (n=6). In the RA, linopirdine reduced relaxation to the EPAC activator at both 1 μmol/L (n=6) and 10 μmol/L (n=5), but an additive effect with 1 μmol/L paxilline was not seen (n=4).
Relaxations to 5 μmol/L 8-pCPT-2Me-cAMP-AM were also tested in the presence of the Kv7.1 inhibitor HMR1556 (10 μmol/L) and the EPAC inhibitor ESI-09 (300 nmol/L). HMR1556 had no effect on relaxations in either MA or RA (n=3-6). 300 nmol/L ESI-09 significantly inhibited the relaxation in both beds (n=3-5; Figure I in the online-only Data Supplement) without any effect on basal tone. Previous reports have concluded that EPAC relaxations are endothelium dependent, 18, 19 so we tested the effect of 5 μmol/L 8-pCPT-2Me-cAMP-AM in MA endothelium denuded segments, which was assessed by the vasorelaxant response to 10 μmol/L carbachol. Vessels with <20% relaxation to 10 μmol/L carbachol were used for these experiments, and we saw no effect of endothelium denudation on responses to 8-pCPT-2Me-cAMP-AM (n=6; Figure II in the online-only Data Supplement).
To test the effect of EPAC stimulation directly on Kv7 channels, we used myocytes isolated from RA and MA and recorded whole cell K + currents, which were sensitive to 10 μmol/L linopirdine (in the presence of 1 μmol/L paxilline) before and after application of 1 μmol/L 8-pCPT-2Me-cAMP-AM. In both RA and MA arterial myocytes, we recorded a significant increase in the linopirdine-sensitive current in the presence of the EPAC activator ( Figure 1D and 1E). We also used HEK293 (human embryonic kidney 293) cells, which stably express Kv7.4-the most abundant Kv7 isoform in the vasculature shown to be enhanced by cAMP [20] [21] [22] and the isoform that has been most commonly implicated in mediating vasorelaxations. [1] [2] [3] [4] [5] [23] [24] [25] [26] [27] [28] [29] [30] End point PCR showed that these cells express both the EPAC1 and EPAC2 isoforms ( Figure  III in the online-only Data Supplement). Kv7.4 channels produce voltage-dependent currents when expressed in HEK293 cells, which increased significantly after addition of 1 μmol/L 8-pCPT-2Me-cAMP-AM (1.6±0.3 times increase maximal current at −20 mV in control; n=7; Figure 1F ). This was associated with a leftward shift of the activation curve, with a change in V1/2 from −7.2 mV in control to −17.5 mV after addition of 1 μmol/L 8-CPT-2Me-cAMP (n=7; Figure 1G ).
Signaling Pathways Involved in Isoproterenol Relaxations
We next sought to establish whether EPAC-dependent signaling via Kv7 channels contributes to isoproterenol-mediated vasorelaxations. Isoproterenol produced dose-dependent relaxations of MA, which were significantly attenuated in the presence of 10 μmol/L linopirdine (Figure 2A ; n=9) or 1 μmol/L paxilline, and an additive inhibitory effect was seen when both agents were used ( Figure 2B ; n=5). This same pattern was seen in the RA ( Figure 2C and 2D; n=5-7), where the role of Kv7 and other K + channels in isoproterenol relaxations has previously been fully characterized. 1 In MA, blockade of ATP-sensitive K+ channels (10 μmol/L glibenclamide) had no effect on relaxations while nonspecific Kv blockade (1 mmol/L 4-aminopyridine) enhanced vasorelaxations (n=4-6; Figure IV in the online-only Data Supplement).
In the MA inhibition of EPAC with 100 nmol/L, ESI-09 produced a significant impairment of isoproterenol relaxations ( Figure 3A ; n=9). In contrast, PKA inhibition by 1 μmol/L KT5720 ( Figure 3C ; n=10) or 1 μmol/L PKI (protein kinase inhibitor [14-22]-amide; Figure V in the online-only Data Supplement) had no effect on isoproterenol relaxations. Linopirdine (10 μmol/L) inhibited the isoproterenol relaxation in the presence of 1 μmol/L KT5720 (n=7), but not 100 nmol/L ESI-09 (n=6; Figure 3B and 3D). To investigate whether there was any isoform specificity in the EPAC-mediated relaxations, we tested the relaxations to isoproterenol in the presence of 1 μmol/L CE3F4 (EPAC1 inhibitor) and 1 μmol/L HJC0350 (EPAC2 inhibitor). Individually, neither had any effect on isoproterenol relaxations ( Figure 3E ; n=6), but in combination, they produced a significant impairment (Figurer 3F; n=5).
Strikingly, EPAC inhibition with 300 nmol/L ESI-09 in the RA had no effect on isoproterenol relaxations ( Figure 4A ; n=5), while PKA inhibition with 1 μmol/L KT5720 (n=9) or 1 μmol/L PKI (n=7) produced a significant inhibition ( Figure 4B and 4C). Consistent with a role for PKA in this vessel, an inhibitor of PKA anchoring (Ht31, 10 μmol/L) produced significant inhibition of the isoproterenol relaxation in RA ( Figure 4D ; n=7).
Using the information obtained in the myograph experiments, we performed proximity ligation assays on both MA and RA myocytes stimulated with 1 μmol/L isoproterenol to detect the localization of several signaling intermediaries with the Kv7.4 subunit. We investigated both AKAP (as a downstream modulator of PKA) and Rap proteins (downstream of EPAC). In MA, there was an increase in Kv7.4-Rap1a ( Figure 5A ; N=3, n=16) and Kv7.4-Rap2 after isoproterenol stimulation ( Figure 5B ; N=3, n=15). High basal levels of Kv7.4-AKAP were detected, but surprisingly these decreased significantly in stimulated cells ( Figure 5C ; N=4, n=19). Conversely, in RA, Kv7.4-AKAP levels increased after isoproterenol treatment ( Figure 6C ; N=3, n=15), but no increase in Kv7.4-Rap1a ( Figure 6A ; N=3, n=13) or Kv7.4-Rap2 was seen ( Figure 6B ; N=2, n=10). There was no change in Kv7.4-Rap1b levels in 
Discussion
Here, we provide the first evidence that EPAC-dependent relaxations involve Kv7 channels and that EPAC signaling contributes to an endogenous vasodilatory response in the rat MA. To our knowledge, this is the first account of an activation of an ion channel by the same endogenous vasodilator via different intracellular signaling pathways. Moreover, we show that the signaling intermediate linking β-adrenoceptors to Kv7 channel differs in RA compared with MA.
Since the discovery of EPAC as a downstream mediator of cAMP signaling, its role in vascular biology has been under scrutiny. EPAC was first shown to be involved in vascular relaxations when a role in the downregulation of RhoA activity resulting in Ca 2+ desensitization was identified. 13 Subsequently, EPAC-dependent relaxation of rat mesenteric arteries was shown to involve BK Ca channel activation. 18 While EPAC had previously been shown to negatively regulate vascular ATP-sensitive K + channel channels, 31 this enhancement of BK Ca was the first account of the positive modulation of a K + channel by EPAC. Our data shows that Kv7 channels underlie, in part, the EPAC-dependent vasorelaxation in rat MA and RA. We, therefore, propose that Kv7 channels are significant players in mediating EPAC-dependent vasorelaxations in the rat vasculature.
Having established that EPAC stimulates Kv7 channels and produces vasorelaxations in a linopirdine-sensitive manner, we investigated the role of EPAC signaling in a receptor-mediated vasorelaxant pathway. Isoproterenol is a well-characterized cAMP generator and vasorelaxant. In the MA, the potassium channel(s) underlying this has been debated for some time. Isoproterenol and cAMP-dependent relaxations were initially believed to involve ATP-sensitive K + channel channels 32 ; however, it has since been shown that although this results in membrane hyperpolarization, [33] [34] [35] these channels do not contribute directly to vasorelaxation because glibenclamide has no effect on these relaxations (see Omar et al, 36 White et al, 37 Huang and Kwok, 38 and present study). The BK Ca channel has also been implicated in the vasoactive properties of isoproterenol (see White et al, 37 Huang and Kwok, 38 Beleznai et al, 39 Matsumoto et al, 40 and present study), and we report that like the EPAC-dependent relaxation, this is an effect that is additive to the role of Kv7 channels. Kv7 channels contribute to the EPAC-dependent component, again an interesting parallel with BK Ca channels, which were reported to contribute to a PKA-independent component 37 (prior to the discovery of EPAC). Discovering the mechanisms that dually regulate Kv7 and BK Ca channels in the MA will be an interesting area of future study. Notably, our study did not show a dependence on the endothelium for the EPAC-dependent relaxation as shown previously. 18, 19 While we saw a wide range of relaxation responses to 5 μmol/L 8-CPT-2Me-cAMP, this was not correlated to the responsiveness to 10 μmol/L carbachol. A similar trend, or lack thereof, was seen with the responsiveness of the MA to 1 μmol/L isoproterenol-this varied considerably between vessels, but no clear correlation was seen between this and the response to carbachol ( Figure VII has been debated intensively for many years. 35, [41] [42] [43] From our data with both isoproterenol and 8-CPT-2Me-cAMP, we conclude that our data does not indicate that these are purely endothelial-dependent responses, but this does not rule out a role for the endothelium completely. Therefore, the reason for the variability is unclear, but could represent the inherent differences present in each animal.
We report that isoproterenol-treated MA myocytes show an increase in proximity ligation assays puncta between Kv7.4 and both Rap1a and Rap2-small G proteins downstream of EPAC. Rap1 proteins have crucial effects within the vasculature, 15 with knockout of a singular isoform resulting in gross cardiovascular defects, such as defective platelet function, 44 angiogenesis, 45, 46 and hypertension, 14 while Rap2 proteins are involved in arteriogenesis. 17 Both Rap1a and Rap 2 are involved in membrane translocation of cellular components in the vasculature, 16, 47, 48 and we propose that this may be a possible mechanism that is involved in the response of Kv7.4 channels to EPAC stimulation, although it is not yet clear if this is via direct or indirect effects on the channel and aim to investigate this further.
This work confirms previous findings from our laboratory that Kv7 channels mediate isoproterenol-dependent relaxations in the RA. 1 Similar to the MA, we now report that this is in combination with BK Ca channel activity because inhibitors of either channel attenuated the relaxation. However, we did not see an additive effect of BK Ca and Kv7 channel inhibition as we had in the MA. The reason for this is unclear, but we speculate that it is because of reduced permeability in RA, which is a much tougher vessel than the MA. We further show that unlike the MA, this relaxation is dependent on PKA, and we see an increase in Kv7.4-AKAP localization in RA myocytes after isoproterenol stimulation. AKAP is known to form multifunctional signaling complexes and has been shown to be regulatory to both cardiac (Kv7.1) 7 and neuronal (Kv7.2, 7.3 and 7.5) 8, 9, 49 Kv7 channels. Here, we demonstrate that this could also be an important regulatory mechanism of Kv7 channels in the vasculature, a finding that warrants further study. We investigated the interactions with Kv7.4 because of its crucial role in the regulation of the vasculature, as highlighted by the impact of KCNQ4 knockdown, 4, 27 and the stimulating effect of EPAC on Kv7.4-dependent currents. An overexpression system was used to remove artery-specific ion channel structure, and these experiments represent a proof of concept that side steps the vagaries of individual arteries. However, one caveat to this is that it is known that Kv7.5 channels form heterotetramers with Kv7.4 in the vasculature, 4,50 and Kv7.5 has been shown to be an end point for PKA-dependent signaling in response to isoproterenol treatment in MA. 51 We confirm here previous reports that isoproterenol-dependent relaxations in MA are primarily PKA-independent, 37 suggesting that this modulation of Kv7.5 may play a role of other aspects of the vascular response to isoproterenol. One further complexity is the relationship of EPAC signaling with βγ G proteins, recently shown to enhance Kv7.4 channels and necessary for receptor-mediated stimulation in RA smooth muscle cells. 22 This study reveals a complex regulation of Kv7 channels by cAMP-dependent signals, which is artery specific. That isoproterenol-mediated signaling couples to Kv7 channels via a PKA/AKAP axis in the RA, but an EPAC/Rap axis in the MA, is highly intriguing. Our data shows that EPAC stimulation is capable of producing Kv7-dependent relaxations in the RA, showing that it is not the case that this pathway is redundant here. One possible explanation is that EPAC is known to be under the control of distinct, compartmentalized molecular complexes that display specific cellular distribution. That EPAC-dependent signals involve Kv7 channels in the vasculature is another step in unraveling the complexities of vascular. 
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